General Information of the Compound
| Compound ID |
CP0034995
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
6‐phenylpteridine‐2,4,7‐triamine (5)
Show/Hide
|
||||||||||||||||||
| Synonyms |
2,4,7-Triamino-6-fenilpteridina
2,4,7-Triamino-6-fenilpteridina [Italian]
2,4,7-Triamino-6-phenylpteridine
6-PHENYL-2,4,7-TRIAMINO PTERIDINE
6-Phenyl-2,4,7-pteridinetriamine
6-Phenyl-2,4,7-triaminopteridine
6-phenylpteridine-2,4,7-triamine
Ademin
Ademin(e)
Ademine
Amteren
Anjal
Apo-triazide
Dazid
Diarol
Dinazide
Diren
Ditak
Diucelpin
Diurene
Diutensat
Diuteren
Dyberzide
Dyren
Dyrenium
Dyrenium (TN)
Dytac
Dytenzide
Esiteren
Fluss 40
Goldshield Brand of Triamterene
Hidiurese
Hydrene
Hypertorr
Isobar
Jatropur
Jenateren
Jorba Brand of Triamterene
Kalspare
Masuharmin
Nephral
Noridil
Noridyl
Pter ophene
Pteridine deriv. 11
Pterofen
Pterophene
Renezide
Reviten
SALI-PUREN
SK&F 8542
SK&F-8542
SK-8542
SKF 8542
SmithKline Beecham Brand of Triamterene
T 4143
TRIAMTERENE USP
Taturil
Teriam
Teridin
Thiazid Wolff
Tri-Span
Triamizide
Triampur
Triamteren
Triamterena
Triamterena [INN-Spanish]
Triamterene
Triamterene (JP15/USP/INN)
Triamterene [USAN:INN:BAN:JAN]
Triamterenum
Triamterenum [INN-Latin]
Triamteril
Triamteril complex
Triamterine
Triamthiazid
Tricilone
Trispan
Triteren
Triurene
Trizid
Turfa
Uretren
Urocaudal
Wellspring Brand of Triamterene
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C12H11N7
|
||||||||||||||||||
| Molecular Weight |
253.269
|
||||||||||||||||||
| Canonical SMILES |
Nc1nc(N)c2nc(c(N)nc2n1)-c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C12H11N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H6,13,14,15,17,18,19)
Show/Hide
|
||||||||||||||||||
| InChIKey |
FNYLWPVRPXGIIP-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
396-01-0
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00817, Cytochrome P450 2D6
Protein ID: PT06109, Geminin
Protein ID: PT02997, Isocitrate dehydrogenase [NADP] cytoplasmic
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Protein ID: PT01214, Tyrosine-protein kinase JAK2
Clinical Information about the Compound